Results 101 to 110 of about 65,201 (219)

Real‐World Survival Outcomes in EGFR‐Mutant Advanced NSCLC Treated With EGFR TKIs: Insights From a Single‐Center Clinical Data Warehouse Analysis in South Korea

open access: yesAsia-Pacific Journal of Clinical Oncology, Volume 22, Issue 3, Page 464-472, June 2026.
This retrospective cohort study was conducted using clinical data derived from a single‐center clinical data warehouse (CDW). In Korean patients with EGFR‐mutant advanced NSCLC, first‐line treatment with 3G EGFR TKIs (osimertinib or lazertinib) demonstrated significantly better overall survival than 1G or 2G agents.
Bomi Kim   +3 more
wiley   +1 more source

A Case of Advanced Prostate Fibrosarcoma that Reacted Well to Chemotherapy [PDF]

open access: yes, 2014
Prostate fibrosarcoma is an extremely rare tumor for which complete excision has been the mainstay of treatment. Although chemotherapy has been attempted in cases with positive surgical margins and/or advanced stage disease, the effectiveness of this ...
加藤, 晴朗   +7 more
core  

Primary ureteral undifferentiated sarcoma with rapid intra‐abdominal recurrence in a dog

open access: yesVeterinary Record Case Reports, Volume 14, Issue 2, May 2026.
Abstract A 3‐year‐old female spayed puli was presented for trembling, lethargy, panting and anorexia. An abdominal computed tomography (CT) scan revealed a mass arising from the right ureter. Peritoneal effusion was detected and confirmed to be uroabdomen. A right ureteronephrectomy was performed.
Emily A. Pope   +4 more
wiley   +1 more source

Locally advanced sinonasal squamous cell carcinoma presenting as oral pain in a dog

open access: yesVeterinary Record Case Reports, Volume 14, Issue 2, May 2026.
Abstract An 11‐year‐old, female, spayed, mixed breed dog was presented with a 1‐month history of oral pain. No major physical abnormalities were reported. A comprehensive oral examination was recommended. At intubation, temporomandibular joint crepitus and decreased range of motion were observed.
Jocosa Yasenchack   +4 more
wiley   +1 more source

Aggressive Fibromatosis in Neck. [PDF]

open access: yes, 2013
Aggressive fibromatosis (AF) is a locally aggressive infiltrative low-grade benign tumor that accounts for approximately less than 3% of all soft tissue tumors.
Bhagat, S   +5 more
core  

? Angio-Fibrosarcoma [PDF]

open access: yesProceedings of the Royal Society of Medicine, 1935
W N, Goldsmith, W, Freudenthal
openaire   +2 more sources

Uterine adenocarcinoma—A rare cause of chronic weight loss in mares

open access: yesVeterinary Record Case Reports, Volume 14, Issue 2, May 2026.
Abstract Diagnosing the cause of slowly progressing weight loss in mares may be challenging, especially when only accompanied by non‐specific and weak clinical signs and non‐specific biochemical and haematological alterations. A 15‐year‐old mare presented with a history of weight loss, anorexia and fever.
Hanne Gervi Pedersen   +3 more
wiley   +1 more source

Fibrosarcoma [PDF]

open access: yes, 2020
Candace Moore   +2 more
  +4 more sources

Integumentary fibrosarcoma in a free‐living swan (Cygnus olor): Medical and welfare considerations

open access: yesVeterinary Record Case Reports, Volume 14, Issue 2, May 2026.
Abstract A 10‐kg adult male mute swan (Cygnus olor) of unknown age was admitted for investigations of two large ventral masses overlying the keel bone, which were discharging purulent material. The masses measured 8.9 × 2.1 cm and 4.2 × 3.2 cm. Empirical treatment with non‐steroidal anti‐inflammatory drugs and antimicrobials was instigated.
Rachael Amy McKinney, Katherine Hughes
wiley   +1 more source

Capacity of different cell types to stimulate cytotoxic T lymphocyte precursor cells in the presence of interleukin 2 [PDF]

open access: yes, 1984
Plastic-adherent cells enriched for dendritic cells (AC) were found to be among the most potent stimulator cells for the activation of cytotoxic T lymphocytes (CTL) in vitro in the presence of interleukin 2 (IL 2) and a constant second set of allogeneic ...
Dröge, W.   +6 more
core  

Home - About - Disclaimer - Privacy